These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31792351)

  • 1. A brief review of the histopathology of proliferative vitreoretinopathy (PVR).
    Mudhar HS
    Eye (Lond); 2020 Feb; 34(2):246-250. PubMed ID: 31792351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational and clinical advancements in management of proliferative vitreoretinopathy.
    Shahlaee A; Woeller CF; Philp NJ; Kuriyan AE
    Curr Opin Ophthalmol; 2022 May; 33(3):219-227. PubMed ID: 35220328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
    Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
    Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy.
    Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.
    Sharma M; Tiwari A; Sharma S; Bansal R; Gupta V; Gupta A; Luthra-Guptasarma M
    Clin Exp Ophthalmol; 2014 Nov; 42(8):745-60. PubMed ID: 24612444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferative vitreoretinopathy: pathophysiology and clinical diagnosis].
    Rouberol F; Chiquet C
    J Fr Ophtalmol; 2014 Sep; 37(7):557-65. PubMed ID: 24997864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of macrophage migration inhibitory factor (MIF) in the effects of oxidative stress on human retinal pigment epithelial cells.
    Ko JA; Sotani Y; Ibrahim DG; Kiuchi Y
    Cell Biochem Funct; 2017 Oct; 35(7):426-432. PubMed ID: 28906008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical therapeutics for proliferative vitreoretinopathy in retinal detachment.
    Sabatino F; Banerjee P; K Muqit MM
    Surv Ophthalmol; 2024; 69(4):508-520. PubMed ID: 38492583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy.
    Ishikawa K; He S; Terasaki H; Nazari H; Zhang H; Spee C; Kannan R; Hinton DR
    Sci Rep; 2015 Nov; 5():16386. PubMed ID: 26552368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells.
    Duan Y; Wu W; Cui J; Matsubara JA; Kazlauskas A; Ma G; Li X; Lei H
    BMC Ophthalmol; 2023 Aug; 23(1):344. PubMed ID: 37537538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells.
    Yin Y; Liu S; Liu H; Wu W
    Biomed Pharmacother; 2023 Oct; 166():115403. PubMed ID: 37659204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Proliferative Vitreoretinopathy Is Attenuated by Chicken Ovalbumin Upstream Promoter Transcriptional Factor 1 Via Inhibiting Epithelial-Mesenchymal Transition.
    Jin H; Cai W; Yu D; Fan J; Liu Q; Yu J
    Discov Med; 2022; 34(172):103-113. PubMed ID: 36333112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology.
    Heffer AM; Proaño J; Roztocil E; Phipps RP; Feldon SE; Huxlin KR; Sime PJ; Libby RT; Woeller CF; Kuriyan AE
    PLoS One; 2019; 14(9):e0222596. PubMed ID: 31527897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
    BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
    Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRT8 phosphorylation regulates the epithelial-mesenchymal transition in retinal pigment epithelial cells through autophagy modulation.
    Miao Q; Xu Y; Yin H; Zhang H; Ye J
    J Cell Mol Med; 2020 Mar; 24(5):3217-3228. PubMed ID: 32022439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy.
    Yang S; Li H; Yao H; Zhang Y; Bao H; Wu L; Zhang C; Li M; Feng L; Zhang J; Zheng Z; Xu G; Wang F
    Cell Death Differ; 2021 Aug; 28(8):2351-2366. PubMed ID: 33664479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
    Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.